WOFIE augments the immunosuppressive potency of FK-506

By Dresske B.   Zavazava N.   Huang D.-S.   Lin X.   Kremer B.   Fandrich F.  

Transplant Immunology, Vol. 6, Iss. 4, 1998-12 ,pp. : 243-249

Elsevier

Access to resources Recommend Favorite

FK 506 as Primary Immunosuppressive Therapy in Renal Transplantation

By Preston R.   Ball S.   Cairns T.   Contis J.   Hakim N.   Palmer A.   Papalois V.   Taube D.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1214-1215

Elsevier

Access to resources Recommend Favorite

Predominant Role of Local Immunosuppressive Effect in Enhanced Efficacy of Liposomal FK506 in Organ Transplantation

By Ko S.   Nakajima Y.   Kanehiro H.   Hisanaga M.   Horikawa M.   Aomatsu Y.   Yagura K.   Kin T.   Ohyama T.   Nishio K.   Yamada T.   Nakano H.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 529-531

Elsevier

Access to resources Recommend Favorite

Effect of local immunosuppressive therapy with FK 506 on renal allograft survival in the mongrel dog

By Yoshimura N.   Hamashima T.   Nakamura K.   Sudo Y.   Yura H.   Oka T.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3110-3111

Elsevier

Access to resources Recommend Favorite

Effect of an immunosuppressive agent, tacroliums (FK-506), on the activities of cytochrome P-450-linked monooxygenase systems of rat liver microsomes

By Izuishi K.   Fujiwara M.   Hossain M.A.   Usuki H.   Maeta H.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 575-576

Elsevier

Access to resources Recommend Favorite